Literature DB >> 9008508

Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm.

L Fratiglioni1, M Viitanen, E von Strauss, V Tontodonati, A Herlitz, B Winblad.   

Abstract

OBJECTIVE: To determine the incidence of different types of dementia in the very old, and to explore the relation with age and gender.
DESIGN: A dementia-free cohort was followed for an average of three years in Stockholm, Sweden. At the end of the follow-up, the subjects were interviewed by nurses, clinically examined by physicians, and cognitively assessed by psychologists. Deceased cohort members were studied using death certificates, hospital clinical records, and discharge diagnoses. Dementia diagnoses were made according to the DSM-III-R criteria independently by two physicians. PARTICIPANTS: The cohort consisted of 1,473 subjects (75+ years old), of which 987 were clinically examined at follow-up, 314 died before the examination, and 172 refused to participate.
RESULTS: During the follow-up, 148 subjects developed dementia. In the age-group 75 to 79, the incidence rates for dementia were 19.6 for women and 12.4 for men per 1,000 person-years, whereas for 90+ year-old subjects the corresponding figures were 86.7 and 15.0 per 1,000 person-years. A similar pattern of distribution by age and gender was seen for Alzheimer's disease. In each age stratum, the incidence rates of dementia and Alzheimer's disease were higher for women than for men. The age-adjusted odds ratio for women was 1.9 for dementia and 3.1 for Alzheimer's disease.
CONCLUSIONS: (1) The incidence of dementia increases with age, even in the oldest age groups; (2) women have a higher risk of developing dementia than men, especially at very old ages; (3) this pattern is mainly due to the age and gender distribution of Alzheimer's disease, rather than vascular dementia.

Entities:  

Mesh:

Year:  1997        PMID: 9008508     DOI: 10.1212/wnl.48.1.132

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  115 in total

1.  Memory improvement in assisted living elders.

Authors:  G J McDougall
Journal:  Issues Ment Health Nurs       Date:  2000-03       Impact factor: 1.835

2.  Costs of Mini Mental State Examination-related cognitive impairment.

Authors:  L Jönsson; P Lindgren; A Wimo; B Jönsson; B Winblad
Journal:  Pharmacoeconomics       Date:  1999-10       Impact factor: 4.981

Review 3.  Hormonal influences on cognition and risk for Alzheimer's disease.

Authors:  Sarah C Janicki; Nicole Schupf
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

Review 4.  Diagnosing dementia in the oldest-old.

Authors:  Carrie Brumback-Peltz; Archana B Balasubramanian; María M Corrada; Claudia H Kawas
Journal:  Maturitas       Date:  2011-08-09       Impact factor: 4.342

Review 5.  Neuroimmunology and neuroepigenetics in the establishment of sex differences in the brain.

Authors:  Margaret M McCarthy; Bridget M Nugent; Kathryn M Lenz
Journal:  Nat Rev Neurosci       Date:  2017-06-22       Impact factor: 34.870

Review 6.  Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression.

Authors:  James A Mortimer; Amy R Borenstein; Karen M Gosche; David A Snowdon
Journal:  J Geriatr Psychiatry Neurol       Date:  2005-12       Impact factor: 2.680

7.  The difficulty of opening medicine containers in old age: a population-based study.

Authors:  Anna Beckman; Cecilia Bernsten; Marti G Parker; Mats Thorslund; Johan Fastbom
Journal:  Pharm World Sci       Date:  2005-10

Review 8.  Anti-dementia drugs and hippocampal-dependent memory in rodents.

Authors:  Carla M Yuede; Hongxin Dong; John G Csernansky
Journal:  Behav Pharmacol       Date:  2007-09       Impact factor: 2.293

9.  Gender dependent APP processing in a transgenic mouse model of Alzheimer's disease.

Authors:  S Schäfer; O Wirths; G Multhaup; T A Bayer
Journal:  J Neural Transm (Vienna)       Date:  2006-10-31       Impact factor: 3.575

Review 10.  The Potential of Gonadal Hormone Signalling Pathways as Therapeutics for Dementia.

Authors:  X Du; R A Hill
Journal:  J Mol Neurosci       Date:  2016-08-15       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.